Cyproheptadine in Preventing Weight Loss in Children Receiving Chemotherapy for Cancer

NCT01132547 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

22

Enrollment

OTHER

Sponsor class

Stopped The study was terminated due to slow accrual.

Conditions

Cancer

Interventions

DRUG: cyproheptadine hydrochloride
OTHER: placebo

Sponsor

University of South Florida

Collaborators

[object Object]